Skip to main content

Table 2 Correlation between dimethylarginines and inflammatory markers

From: Association of dimethylarginines and mediators of inflammation after acute ischemic stroke

  6 h 12 h 24 h 3 d 7 d
  R P R P R P R P R P
ADMA vs. IL-6 0.059 0.659 −0.024 0.860 0.001 0.997 0.272 0.039 0.344 0.008
ADMA vs. CRP −0.192 0.149 0.113 0.397 0.031 0.819 0.291 0.027 0.338 0.010
ADMA vs. S100B −0.106 0.430 −0.073 0.585 0.144 0.279 0.082 0.540 0.214 0.106
ADMA vs. MMP-9 −0.104 0.440 −0.153 0.254 0.131 0.330 0.031 0.818 0.039 0.775
ADMA vs. TIMP-1 0.346 0.010 0.083 0.545 0.401 0.002 0.431 0.001 0.352 0.008
ADMA vs. MCP-1 0.179 0.179 −0.026 0.844 0.012 0.930 0.213 0.108 0.209 0.116
SDMA vs. IL-6 0.237 0.073 0.219 0.099 0.139 0.297 0.389 0.003 0.405 0.002
SDMA vs. CRP −0.144 0.281 0.017 0.899 −0.023 0.863 0.207 0.119 0.197 0.138
SDMA vs. S100B −0.110 0.410 0.033 0.808 0.135 0.313 0.036 0.788 0.182 0.170
SDMA vs. MMP-9 −0.062 0.649 −0.115 0.393 −0.132 0.329 −0.015 0.913 0.055 0.684
SDMA vs. TIMP-1 0.237 0.082 −0.015 0.914 0.048 0.726 0.170 0.215 0.271 0.046
SDMA vs. MCP-1 0.379 0.003 0.149 0.264 0.110 0.411 0.286 0.030 0.345 0.008
  1. P <0.05 is considered statistically significant. ADMA, asymmetric dimethylarginine; CRP, C-reactive protein; IL-6, interleukin-6; MCP-1, monocyte chemotactic protein-1; MMP-9, matrix metalloproteinase-9; SDMA, symmetric dimethylarginine; TIMP-1, tissue inhibitor of matrix metalloproteinase-1.